These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37311506)

  • 1. Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.
    Veider F; Knoll P; Jörgensen AM; Stengel D; Bernkop-Schnürch A
    Acta Biomater; 2023 Sep; 167():416-424. PubMed ID: 37311506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG vs. zwitterions: How these surface decorations determine cellular uptake of lipid-based nanocarriers.
    Stengel D; Demirel BH; Knoll P; Truszkowska M; Laffleur F; Bernkop-Schnürch A
    J Colloid Interface Sci; 2023 Oct; 647():52-64. PubMed ID: 37244176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface.
    Friedl JD; Steinbring C; Zaichik S; Le NN; Bernkop-Schnürch A
    Nanomedicine (Lond); 2020 Aug; 15(19):1829-1841. PubMed ID: 32781886
    [No Abstract]   [Full Text] [Related]  

  • 4. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier.
    Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A
    Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zeta potential changing nanoemulsions based on a simple zwitterion.
    Sharifi F; Jahangiri M; Nazir I; Asim MH; Ebrahimnejad P; Hupfauf A; Gust R; Bernkop-Schnürch A
    J Colloid Interface Sci; 2021 Mar; 585():126-137. PubMed ID: 33279695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures.
    Akbari A; Lavasanifar A; Wu J
    Acta Biomater; 2017 Dec; 64():249-258. PubMed ID: 29030304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming intestinal barriers by heparanase-responsive charge-converting nanocarriers.
    Veider F; Zöller K; Saleh A; Bernkop-Schnürch A
    Int J Pharm; 2024 Feb; 651():123817. PubMed ID: 38237708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery.
    Friedl JD; Jörgensen AM; Nguyen Le NM; Steinbring C; Bernkop-Schnürch A
    Int J Pharm; 2022 Apr; 618():121633. PubMed ID: 35304244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
    Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
    Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Intestinal Uptake And Permeability Of Fluorescently-Labelled Hyaluronic Acid Nanogels.
    Xavier M; García-Hevia L; Amado IR; Pastrana L; Gonçalves C
    Int J Nanomedicine; 2019; 14():9077-9088. PubMed ID: 31819420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
    Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption.
    Liang Y; Ding R; Wang H; Liu L; He J; Tao Y; Zhao Z; Zhang J; Wang A; Sun K; Li Y; Shi Y
    Drug Deliv; 2022 Dec; 29(1):305-315. PubMed ID: 35037529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.
    Thwala LN; Beloqui A; Csaba NS; González-Touceda D; Tovar S; Dieguez C; Alonso MJ; Préat V
    J Control Release; 2016 Dec; 243():109-120. PubMed ID: 27720993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.
    Anderski J; Mahlert L; Mulac D; Langer K
    Eur J Pharm Biopharm; 2018 Aug; 129():1-9. PubMed ID: 29778525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier.
    Nazir I; Fürst A; Lupo N; Hupfauf A; Gust R; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2019 Nov; 144():40-49. PubMed ID: 31505225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
    Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
    Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
    Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.